The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Stool microbiota profiling of patients with muscle invasive bladder cancer receiving neoadjuvant pembrolizumab.
 
Filippo Pederzoli
No Relationships to Disclose
 
Irene Locatelli
No Relationships to Disclose
 
Michela Riba
No Relationships to Disclose
 
Marco Bandini
Travel, Accommodations, Expenses - ASCO
 
Daniele Raggi
No Relationships to Disclose
 
Laura Marandino
No Relationships to Disclose
 
Elisa Alchera
No Relationships to Disclose
 
Patrizia Giannatempo
No Relationships to Disclose
 
Paolo Provero
No Relationships to Disclose
 
Dejan Lazarevic
No Relationships to Disclose
 
Roberta Lucianò
No Relationships to Disclose
 
Andrea Gallina
No Relationships to Disclose
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen-Cilag; MDxHealth; OPKO Health
Speakers' Bureau - Astellas Pharma
Research Funding - Merck Sharp & Dohme; Sandoz-Novartis
 
Francesco Montorsi
No Relationships to Disclose
 
Andrea Salonia
Speakers' Bureau - Astellas Pharma
Travel, Accommodations, Expenses - Konpharma
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Ferring; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Ipsen; Merck Sharp & Dohme (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Massimo Alfano
No Relationships to Disclose